Citations

Mayo Clinic

Showing 10 of 108551 citations.

Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC‐NCS)
Li, Danni , Misialek, Jeffrey R. , Boerwinkle, Eric , Sharrett, A. Richey, Wruck, Lisa , Gottesman, Rebecca F. , Mosley, Thomas H. , Coresh, Josef , Knopman, David S. , Alonso, Álvaro , Wruck, Lisa M

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | May 6, 2016 | Volume: 3 | Issue: 1 | Pages: 73-82

10.1016/j.dadm.2016.02.008 | PMID 27408938 Get It

AbstractIntroductionPhospholipids are altered in brains of patients with dementia and some studies suggest their plasma levels may be useful in the detection of mild cognitive impairment (MCI) and dementia.MethodsWe measured 188 plasma metabolites in participants who underwent a detailed neuropsychological assessment and classified as normal (n = 153), MCI (n = 145), or dementia (n = 143) by expert adjudication.ResultsAmong 10 phospholipids recently implicated as altered in dementia, higher concentration of PC aa C36:6 was significantly associated with decreased prevalence of dementia (odds ratio = 0.71, 95% confidence interval = 0.50–1.00 per 1−SD increase). Adding these phospholipids to a model including multiple predictors of dementia led to only minimal improvement in detection (C statistic changed from 0.702 to 0.71).DiscussionSome phospholipids and metabolites were altered in MCI and dementia but cross‐sectional association was relatively weak and did not improve detection of MCI and dementia beyond information provided by clinical variables.
A new pattern of lipomatosis of nerve: case report
Prasad, Nikhil , Howe, Benjamin M. , Amrami, Kimberly K. , Spinner, Robert J. , Mahan, Mark A

Journal of Neurosurgery | May 6, 2016 | Volume: 126 | Issue: 3 | Pages: 933-937

10.3171/2016.2.jns151051 | PMID 27153174 Get It

Lipomatosis of nerve (LN) is a rare disorder of peripheral nerves that produces proliferation of interfascicular adipose tissue. It may be associated with soft-tissue and bony overgrowth within the affected nerve territory. LN has been almost exclusively reported in appendicular peripheral nerves; the median nerve at the wrist and palm is among the most common locations. The authors present a new pattern of LN that shows circumferential proliferation of fat around the epineurium of the nerve. They believe that this case and the two other documented examples in the literature (also affecting cervical and thoracic spinal nerves) share the same new pattern of LN. Defining the full spectrum of adipose lesions of the nerve and establishing a cause-effect relationship with nerve-territory overgrowth disorders may offer options for future management through targeted nerve lesioning.
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction
Gulati, Rajiv , Gersh, Bernard J.

Circulation | May 6, 2016 | Volume: 133 | Issue: 22 | Pages: 2125-2127

10.1161/circulationaha.116.022733 | PMID 27151533 Get It

Introducing routine HIV screening for patients on an internal medicine residency inpatient service: a quality improvement project
Padrnos, Leslie , Barr, Patrick J, Klassen, Christine L. , Fields, Heather , Azadeh, Natalya , Mendoza, N. S., Pauwels, Emanuel M, King, Christopher S. , Chung, Andrew A., Sakata, Kenneth K. , Blair, Janis E. , Padrnos, Leslie J, Fields, Heather E, Mendoza, Neil, Saadiq, Rayya A. , Mendoza, N. S.

BMJ Quality Improvement Reports | May 5, 2016 | Volume: 5 | Issue: 1 | Pages: u206955.w3030

10.1136/bmjquality.u206955.w3030 | PMID 27239302 Get It

The US Centers for Disease Control and Prevention (CDC) recommend human immunodeficiency virus (HIV) screening for all persons aged 13 to 64 years who present to a health care provider. We sought to improve adherence to the CDC guidelines on the Internal Medicine Resident Hospital Service. We surveyed residents about the CDC guidelines, sent email reminders, provided education, and engaged them in friendly competition. Credit for guideline adherence was awarded if an offer of HIV screening was documented at admission, if a screening test was performed, or if a notation in the resident sign out sheet indicated why screening was not performed. We examined HIV screening of a postintervention group of patients admitted between August 8, 2012, and June 30, 2013, and compared them to a preintervention group admitted between August 1, 2011, and June 30, 2012. Postintervention offers of HIV screening increased significantly (7.9% [44/559] vs 55.5% [300/541]; P<.001), as did documentation of residents' contemplation of screening (8.9% [50/559] vs 67.5% [365/541]; P<.001). A significantly higher proportion of HIV screening tests was ordered postintervention (7.7% [43/559] vs 44.4% [240/541]; P<.001). Monthly HIV screening documentation ranged from 0% (0/53) to 17% (9/53) preintervention, whereas it ranged from 30.6% (11/36) to 100% (62/62) postintervention. HIV screening adherence can be improved through resident education, friendly competition, and system reminders. Barriers to achieving sustained adherence to the CDC guidelines include a heterogeneous patient population and provider discomfort with the subject.
Simple Interventions Improve the Quality of a Missed Lab Appointment Process
Mookadam, Martina , Grover, Michael , Pullins, Chris, Winscott, Mary, Pierce, Susan, Pullins, Christopher , Pierce, Susan

BMJ Quality Improvement Reports | May 5, 2016 | Volume: 5 | Issue: 1 | Pages: u205944.w2432

10.1136/bmjquality.u205944.w2432 | PMID 27239304 Get It

Simple interventions resolve the problem of missed lab appointments. It is essential that patients complete ordered laboratory studies. This maintains clinical quality and, potentially, keeps patients safe from harm. In our academic family medicine practice, baseline data demonstrated patients completed 94.7% of labs as ordered (26850/28348 patients per year) while 1498 (5.3%) did not. Our baseline patient reminder process, a mail or portal based generic letter, resulted in only 449 (30%) of patients ultimately completing them (1049 [70%] did not). Our baseline system was 96.3 % reliable. This process did not allow for provider review or input, and was not personalized for patients. We designed a quality improvement project involving three PDSA (Plan, Do, Study, and Act) cycles of about two months each. Desk staff created weekly reports of unresolved lab orders. A message in the electronic medical record (EMR) solicited provider input. Providers could elect to cancel studies (if already completed, reordered, or no longer clinically indicated) or have the patient receive a personalized reminder, including provider name and associated diagnoses. This reminder was sent by patient portal secure messaging (if an account existed) or with a mailed letter. These interventions resulted in 98.8 % process reliability. The frequency of unresolved lab orders decreased from 70% at baseline to 25%. In the second PDSA cycle, we contacted patients by the portal only if there was evidence of an active account. Otherwise, they were contacted by telephone. Patients without a portal account continued to receive a letter by mail. These modified processes resulted in an overall reliability rate of 99.2%. The frequency of unresolved lab orders decreased to 17%. A final PDSA cycle utilized only telephone contact with patients with unresolved lab orders. Schedulers offered patients a choice of appointment dates if they spoke personally. Otherwise, they were left messages with a future lab appointment date two weeks later.Overall process reliability now increased to 100%. The frequency of unresolved lab orders decreased to 0%. Our interventions resulted in increased system reliability.Provider input was not perceived as burdensome. Desk staff work effort was not increased.Telephone patient contact resulted in more frequent lab order completion than other methods.
Incidence, Characteristics, and Implications of Seizures in Patients With Glioblastoma
Shin, John Y. , Kizilbash, Sani H. , Uhm, Joon H. , Jatoi, Aminah , Robinson, Steven, Robinson, Steven I. , Kizilbash, Sani H

American Journal of Hospice and Palliative Medicine® | May 5, 2016 | Volume: 34 | Issue: 7 | Pages: 650-653

10.1177/1049909116647405 | PMID 27151973 Get It

Background: Seizures in patients with glioblastoma are associated with worse quality of life. However, their incidence, clinical characteristics, and prognostic implications are less well characterized. Objective: This study was undertaken to provide a contemporary experience along with benchmark data relevant to the above in patients with glioblastoma. It also sought to reexplore improved survival with seizures, as observed by others. Methods: In this single-institution study, patients with glioblastoma from 2010 through 2014 had their medical records reviewed in detail. Results: Among 122 patients, 58 (48%) had a seizure history. Of these, 67% had more than 1, 41% had generalized seizures, and most received antiseizure medication (most commonly levetiracetam). The median survival for patients with seizures was 1.66 years and 0.87 years for those without (hazard ratio for risk of death with seizures: 0.72; 95% confidence interval: 0.43, 1.21; P = .22 by the log-rank test). Conclusion: Seizures are common in patients with glioblastoma and, in contrast to earlier reports, are not associated with a statistically significant improvement in survival.
Elevated urinary podocyte-derived extracellular microvesicles in renovascular hypertensive patients
Kwon, Soon Hyo , Woollard, John R. , Saad, Ahmed , Zand, Ladan , Jordan, Kyra L., Textor, Stephen C., Lerman, Lilach O. , Garovic, Vesna D.

Nephrology Dialysis Transplantation | May 5, 2016 | Volume: 32 | Issue: 5 | Pages: 800-807

10.1093/ndt/gfw077 | PMID 27190371 Get It

ABSTRACT Background: An increased number of podocyte-derived extracellular vesicles (pEVs) may reflect podocyte injury in renal disease. Elevated glomerular pressure and other insults may injure podocytes, yet it remains unclear whether the numbers of pEVs are altered in hypertensive patients. We tested the hypothesis that urinary pEV levels would be elevated in patients with renovascular hypertension (RVH) compared with essential hypertension (EH) or healthy volunteers (HVs). Methods: We prospectively enrolled patients with EH (n = 30) or RVH (n = 31) to study renal blood flow (RBF) and cortical perfusion using multidetector computed tomography under controlled condition (regulated sodium intake and renin—angiotensin blockade). After isolation from urine samples, pEVs (nephrin and podocalyxin positive) were characterized by flow cytometry. Fourteen RVH patients were studied again 3 months after stenting or continued medical therapy. HVs (n = 15) served as controls. Results: The fraction of pEV among urinary EVs was elevated in RVH compared with HVs and EH (11.4 ± 6.4, 6.8 ± 3.4 and 6.3 ± 3.7%, respectively; P &lt; 0.001) and remained unchanged after 3 additional months of therapy and after controlling for clinical parameters. However, eGFR- and age-adjusted pEV levels did not correlate with any clinical or renal parameters. Conclusions: In hypertensive patients under controlled conditions, urinary pEV levels are elevated in patients with RVH and low eGFR compared with patients with EH and relatively preserved renal function. These pEVs may reflect podocyte injury secondary to kidney damage, and their levels might represent a novel therapeutic target.
To stent or not to stent: Endovascular treatment of hepatic artery stenosis
Taner, Timuçin , Heimbach, Julie K.

Liver Transplantation | May 5, 2016 | Volume: 22 | Issue: 7 | Pages: 884-885

10.1002/lt.24476 | PMID 27149241 Get It

Prognostic factors in kidney transplantation in the septuagenarian: a multicenter analysis
Saucedo‐Crespo, Hector , Haakinson, Danielle J. , Croome, Kristopher P. , Mai, Martin L., Heilman, Raymond L. , Gonwa, Thomas A., Taner, C. Burcin , Gonwa, Thomas, Mai, Martin L., Croome, Kris P

Clinical Transplantation | May 5, 2016 | Volume: 30 | Issue: 7 | Pages: 828-835

10.1111/ctr.12756 | PMID 27146093 Get It

AbstractKidney transplant (KT) programs have extended recipient eligibility to those who were previously excluded due to advanced age. We aimed to determine the outcomes of the patients ≥70 years undergoing KT and investigate factors predicting survival. Two thousand six hundred and twenty‐four KT patients between 2003 and 2013 at two institutions were divided into two groups; those ≥70 years (n=300) and those <70 years (n=2324) at the time of KT. Patient survival at 1, 3, and 5 years was 95%, 86%, and 77% in ≥70 years of age group and 98%, 95%, and 90% in the <70 years group (P<.001). When graft loss due to death was censored, graft survival was not significantly different between the two groups (P=.18). On multivariable analysis, the significant predictors of inferior survival in patients ≥70 years included: body mass index (BMI)>30 kg/m2 (hazard ratio [HR] 1.07; P=.01), panel reactive antibody (PRA)>20% (HR 2.38; P=.01), previous coronary artery bypass grafting (CABG; HR 1.95; P=.03) and peripheral vascular disease (PVD; HR 2.60; P=.04). Acceptable outcomes can be achieved in KT recipients ≥70 years. Caution should be used when listing these patients if they have BMI>30 kg/m2, PRA>20%, CABG or PVD.
Insight into the molecular pathophysiology of myelodysplastic syndromes: targets for novel therapy
Patnaik, Mrinal M. , Gangat, Naseema , Hashmi, Shahrukh K. , Rizzieri, David A. , Zahid, Mohammad Faizan

European Journal of Haematology | May 5, 2016 | Volume: 97 | Issue: 4 | Pages: 313-320

10.1111/ejh.12771 | PMID 27147278 Get It

AbstractMyelodysplastic syndromes (MDS) are clonal hematopoietic stem cell disorders characterized by abnormal cellular differentiation and maturation with variable progression to acute leukemia. Over the last decade, scientific discoveries have unraveled specific pathways involved in the complex pathophysiology of MDS. Prominent examples include aberrations in cytokines and their signaling pathways (such as tumor necrosis factor‐alpha, interferon‐gamma, SMAD proteins), mutations in genes encoding the RNA splicing machinery (SF3B1, SRSF2, ZRSR2, and U2AF1 genes), mutations in genes disrupting the epigenetic machinery (TET2, DNMT3A, DNMT3B, EZH2, ASXL1). In addition, abnormalities in regulatory T‐cell dynamics and atypical interactions between the bone marrow microenvironment, stroma and progenitor cells, and abnormal maintenance of telomeres are also notable contributors to the complex pathogenesis of MDS. These pathways represent potential targets for novel therapies. Specific therapies include drugs targeting aberrant DNA methylation and chromatin remodeling, modulating/activating the immune system to enhance tumor‐specific cellular immune responses and reduce anomalous cytokine signaling, and blocking abnormal interaction between hematopoietic progenitors and stromal cells.